A new trading day began on Monday, with Sagimet Biosciences Inc (NASDAQ: SGMT) stock price down -5.91% from the previous day of trading, before settling in for the closing price of $9.14. SGMT’s price has ranged from $1.73 to $11.41 over the past 52 weeks.
During the last 5-year period, the sales drop of Healthcare Sector giant was -16.85%. Meanwhile, its annual earnings per share averaged -15.38%. With a float of $26.13 million, this company’s outstanding shares have now reached $30.67 million.
Sagimet Biosciences Inc (SGMT) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Sagimet Biosciences Inc is 19.66%, while institutional ownership is 29.57%. The most recent insider transaction that took place on Jul 21 ’25, was worth 598,115. In this transaction President & CEO of this company sold 65,478 shares at a rate of $9.13, taking the stock ownership to the 689,722 shares. Before that another transaction happened on Jul 21 ’25, when Company’s Chief Medical Officer sold 8,277 for $9.13, making the entire transaction worth $75,607. This insider now owns 106,936 shares in total.
Sagimet Biosciences Inc (SGMT) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.45 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.43 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -15.38% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -15.10% during the next five years compared to -16.85% drop over the previous five years of trading.
Sagimet Biosciences Inc (NASDAQ: SGMT) Trading Performance Indicators
Here are Sagimet Biosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 17.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.85, a number that is poised to hit -0.39 in the next quarter and is forecasted to reach -1.94 in one year’s time.
Technical Analysis of Sagimet Biosciences Inc (SGMT)
Looking closely at Sagimet Biosciences Inc (NASDAQ: SGMT), its last 5-days average volume was 0.98 million, which is a jump from its year-to-date volume of 0.98 million. As of the previous 9 days, the stock’s Stochastic %D was 55.22%.
During the past 100 days, Sagimet Biosciences Inc’s (SGMT) raw stochastic average was set at 62.08%, which indicates a significant decrease from 62.77% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.75 in the past 14 days, which was higher than the 0.74 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.27, while its 200-day Moving Average is $5.75. However, in the short run, Sagimet Biosciences Inc’s stock first resistance to watch stands at $9.27. Second resistance stands at $9.93. The third major resistance level sits at $10.41. If the price goes on to break the first support level at $8.13, it is likely to go to the next support level at $7.65. Should the price break the second support level, the third support level stands at $6.99.
Sagimet Biosciences Inc (NASDAQ: SGMT) Key Stats
With a market capitalization of 266.61 million, the company has a total of 32,522K Shares Outstanding. Currently, annual sales are 0 K while annual income is -45,570 K. The company’s previous quarter sales were 0 K while its latest quarter income was -10,390 K.
